Granules India’s Vizag facility completes US FDA inspection with zero 483 observations
This facility manufactures APIs and formulations of oncology and non-oncology products
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
483 observations
Dr Reddy’s gets four observations from USFDA for Srikakulam plant
The audit of the company's API Srikakulam Plant (SEZ) was completed last week
LifeSan Clinical Research receives zero 483 observations from US FDA
The observation signifies compliance and conformance to applicable GCP regulations LifeSan Clinical Research, the clinical…
Strides completes US FDA inspection at its Alathur facility
The company announced a successful completion of inspection at the facility by US FDA with “Zero 483 observations”